-
Symbol
-
XLO on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
8.14M shares
-
Security Ownership
-
9.9%
Frazier Life Sciences Public Fund, L.P. ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)
2025-08-14 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.14M shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO).
This represents 9.9% percent ownership of the company.
In their previous filing dated 2025-06-12, Frazier Life Sciences Public Fund, L.P. had reported owning 5.75M shares, indicating an increase of 41.7% percent.